Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01172132
NCT01172132
Completed
Not Applicable

Long Term Outcomes in Critically Ill Haematological Patients. The Use of Intensive Care in Critically Ill Cancer Haematological Patients

Assistance Publique - Hôpitaux de Paris1 site in 1 country1,011 target enrollmentNovember 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHematological Malignancies

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hematological Malignancies
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
1011
Locations
1
Primary Endpoint
Survival status at one year
Status
Completed
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to determine:

  • Condition of intensive care unit (ICU) admission in patients with haematological malignancies.
  • ICU hospital and up to one year mortality.
  • Assessment of post ICU burden and health related quality at 90-d and 1 year.

Detailed Description

1. To identify prognostic factors of short and medium term mortality, by underlining the respective weights of organ dysfunction and characteristics of underlined malignancy 2. Evaluate the health related quality of life of intensive care survivors(SF36) 3. Impact of intensive care on families burden (HADS, IES). 4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care nurses) in relation to medical decision-making. 5. Establish the relevance of antifungal treatments.

Registry
clinicaltrials.gov
Start Date
November 2009
End Date
November 2011
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Hematological malignancies
  • •hospitalization in ICU
  • •age \>= 18 years

Exclusion Criteria

  • •Patients who have already participated to TRIAL-OH

Outcomes

Primary Outcomes

Survival status at one year

Time Frame: 1 year

survival status (alive or death) at one year

Secondary Outcomes

  • Survival status(day 90)
  • ICU mortality(1 week (estimated mean time until ICU discharge))
  • Hospital mortality(3 weeks (estimated mean time until Hospital discharge))
  • Health related quality of life of patients and their relatives(day 90 and 1 year)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in ArgentinaRespiratory FailureCovid-19Mechanical Ventilation
NCT04611269Argentinian Intensive Care Society950
Unknown
Not Applicable
Long-term Outcomes of Critical Illness SurvivorsIntensive Care Units
NCT03940755Jian-jun Yang200
Completed
Not Applicable
Long-term Outcomes of Post-intubation Tracheal Stenosis; 7-year Follow-upTracheal StenosisIntensive Care Unit
NCT06121024Ankara Ataturk Sanatorium Training and Research Hospital76
Active, not recruiting
Not Applicable
Critical Care Outcomes of Hematologic Oncology PatientsHematologic MalignancyStem Cell Transplant
NCT03449953Mount Sinai Hospital, Canada415
Recruiting
Not Applicable
Long Term Effects On Recipients of Hematopoietic Stem Cell TransplantationBlood and Marrow Transplant (BMT)
NCT01629017Stanford University800